• Safety & Recalls
  • Regulatory Updates
  • Drug Coverage
  • COPD
  • Cardiovascular
  • Obstetrics-Gynecology & Women's Health
  • Ophthalmology
  • Clinical Pharmacology
  • Pediatrics
  • Urology
  • Pharmacy
  • Idiopathic Pulmonary Fibrosis
  • Diabetes and Endocrinology
  • Allergy, Immunology, and ENT
  • Musculoskeletal/Rheumatology
  • Respiratory
  • Psychiatry and Behavioral Health
  • Dermatology
  • Oncology

First-time generic drug approval, February 2008

Article

First-time generic approval: Granisetron injection

Key Points

Granisetron injection, 1 mg (base)/mL (equiv to Kytril injection)

TEVA

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.